Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer

NCT03073395 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer
Renal Cancer

Interventions

DRUG: [68Ga]P16-093

Sponsor

Five Eleven Pharma, Inc.